샘플 요청 목록

 카트 문의
시장보고서
상품코드
1574960

세계의 복강내 감염증 시장 : 진단별, 용도별, 치료별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율 예측(2024-2032년)

Intra-Abdominal Infections Market, By Diagnosis, By Application, By Treatment, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 269 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

복강내 감염증 시장 규모는 2023년에 225억 9,043만 달러로 2024년부터 2032년까지 연평균 복합 성장률(CAGR) 8.90%로 확대

복강 내 감염증 시장 - 시장 역학

항생제 내성의 상승은 고급 치료 옵션에 대한 수요를 촉진

항생제 내성 박테리아 증가로 복강 내 감염에 대한 더 나은 치료법에 대한 수요가 증가하고 있습니다. 표준 항생제가 효과가 어려워짐에 따라 건강 관리 제공업체는 이러한 감염의 관리를 걱정합니다. 미국 질병 예방관리센터(CDC)의 보고에 따르면 미국에서는 매년 300만 건 가까이 항생제 내성 감염이 발생하고 있으며, 새로운 치료법의 긴급 필요성이 부각되고 있습니다. 이 문제는 환자의 건강에 영향을 줄뿐만 아니라 건강 관리 시스템에도 큰 부담을 주고 있습니다.

이에 대해 연구자와 제약회사는 새로운 항생제와 대체요법을 포함한 새로운 해결책을 다루고 있습니다. 그 목표는 환자의 예후를 개선하고 전통적인 방법으로 해결할 수없는 감염에 대처하기 위해 이러한 고급 치료법을 개발하는 것입니다. 이 전환은 내성 박테리아가 증가하는 동안 더 나은 건강 관리를 보장하기 위해 매우 중요합니다.

복강 내 감염 시장 - 주요 인사이트

우리 리서치 애널리스트의 분석에 따르면 세계 시장은 예측 기간(2024-2032년)에 약 8.90%의 연평균 복합 성장률(CAGR)로 매년 성장할 것으로 추정됩니다.

치료별로, β-락탐 약물은 2023년에 가장 큰 시장 점유율을 나타낼 것으로 예측됐습니다.

용도별로 복강내 농양은 2023년의 주요 유형이었습니다.

진단별로는 컴퓨터 단층촬영(CT)이 2023년의 주요 유형이었습니다.

지역별로는 북미가 2023년 매출에서 최고 부문이었습니다.

복강 내 감염 시장 - 세분화 분석 :

복강 내 감염 세계 시장은 진단, 용도, 치료 및 지역에 따라 세분화됩니다.

시장은 치료별로 세 가지 범주로 나뉩니다: 클로람페니콜계, 베타락탐계, 퀴놀론계, 아미노글리코시드계. 복강내 감염 시장에서는 β-락탐계 약물이 주요 치료 옵션이 되고 있습니다. β-락탐계 항균제는 이러한 감염에 흔히 나타나는 그람 양성균과 그람 음성균을 모두 포함하는 폭넓은 세균을 효과적으로 표적으로 하기 때문에 인기가 높습니다.

페니실린과 세팔로스포린과 같은 베타-락탐 항균제는 효능과 안전성이 높기 때문에 치료의 첫 번째 선택입니다. β락탐계 항균제는 조직에 침투하기 쉽기 때문에 복강내 세균에도 유효합니다. 더 많은 수술이 수행되고 감염이 증가함에 따라, 베타-락타마제 제형 수요는 증가의 길을 따라가고 있으며, 이 시장 부문에서 상위 자리를 굳히고 있습니다.

시장은 용도별로 5개의 범주로 분류됩니다: 복강내 농양, 맹장염, 게실염, 설사, 식중독, 헬리코박터 파일로리에 의한 감염, 기유형니다. 복강 내 감염 시장에서 복강 내 농양은 가장 지배적인 부문입니다. 복강내 농양은 임상 현장에서 자주 볼 수 있으며, 맹장염이나 게실염 등의 합병증으로 발생하는 경우가 많습니다. 복강내 농양은 패혈증과 같은 문제로 이어질 수 있으며 신속하고 효과적인 치료가 필수적입니다. 이러한 감염을 치료하기 위한 수술과 항생제 치료의 필요성도 시장을 뒷받침하고 있습니다.

복강 내 감염 시장 - 지리적 통찰

복강 내 감염 시장에서 가장 규모가 큰 지역은 북미입니다. 이 지역은 병원 수가 많으며 고급 건강 관리 시스템이 이러한 감염의 진단과 치료를 지원합니다. 수술 증가와 비만의 만연은 복강 내 감염 증가로 이어지고 있습니다.

또한 주요 건강 관리 기업에 의한 새로운 치료법의 연구 개발도 활발합니다. 환자는 항생제 및 기타 치료제를 사용할 수 있습니다. 북미 시장은 감염 관리에 대한 의식 증가와 여러 요인들로부터 성장이 예상됩니다.

복강내 감염 시장 - 경쟁 구도:

복강 내 감염 시장에는 이러한 질병에 대한 효과적인 치료법 개발에 주력하는 여러 기업이 있습니다. Merck는 다양한 항생제와 혁신적인 치료제로 시장을 선도하고 있습니다. 화이자는 다양한 효과적인 치료제를 제공하며, AstraZeneca는 이 분야의 연구로 알려져 있습니다.

AbbVie Inc.는 감염과 싸우기 위한 표적 치료에 중점을 두고, Bayer AG은 치료와 지지 요법을 혼합한 것을 제공합니다. GSK(GlaxoSmithKline)도 신약 발견에 대한 투자에 주력하고 있습니다. 복강내 감염에 대한 인식이 높아짐에 따라 이들 기업은 기존 제품의 개선과 새로운 치료법의 도입에 힘차게 하고 시장 성장을 견인하고 있습니다.

목차

제1장 복강내 감염증 시장 개요

  • 조사 범위
  • 시장추정년

제2장 주요 요약

  • 시장 분석
  • 경쟁 인사이트

제3장 복강내 감염증의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장의 미래 동향

제4장 복강내 감염증에 관한 업계 조사

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 맵핑
  • 규제 틀 분석

제5장 복강내 감염증 시장 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 이후의 영향 분석

제6장 복강내 감염증 시장 상황

  • 복강내 감염증 시장 점유율 분석, 2023년
  • 주요 제조업체별 분석 데이터
    • 기존 기업의 분석
    • 신흥기업의 분석

제7장 복강내 감염증 시장- 진단별

  • 개요
    • 진단별 부문 점유율 분석
    • 복부 X선
    • 혈액검사
    • 컴퓨터 단층 촬영(CT)
    • 초음파
    • 기타

제8장 복강내 감염증 시장- 용도별

  • 개요
    • 용도별 부문 점유율 분석
    • 복강내 농양
    • 맹장염
    • 게실염
    • 설사
    • 식중독
    • 헬리코박터 파일로리에 의한 감염
    • 기타

제9장 복강내 감염증 시장-치료별

  • 개요
    • 치료별 부문 점유율 분석
    • 클로람페니콜
    • β락탐
    • 퀴놀론
    • 아미노글리코시드
    • 기타

제10장 복강내 감염증 시장-지역별

  • 소개
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제11장 주요 벤더 분석 - 복강내 감염증 업계

  • 경쟁 대시보드
  • 기업 프로파일
    • Pfizer Inc.
    • Merck &Co., Inc.
    • AstraZeneca PLC
    • Bayer AG
    • Allergan(AbbVie)
    • GlaxoSmithKline plc
    • Eli Lilly and Company
    • Sanofi SA
    • F. Hoffmann-La Roche Ltd
    • Johnson &Johnson
    • Basilea Pharmaceutica Ltd
    • Shionogi &Co., Ltd.
    • Achaogen, Inc.
    • Melinta Therapeutics, Inc.
    • Tetraphase Pharmaceuticals, Inc.
    • The Medicines Company
    • Dr. Reddy's Laboratories Ltd

제12장 애널리스트의 전방위 전망

JHS 24.11.06

REPORT HIGHLIGHT

Intra-Abdominal Infections Market size was valued at USD 22,590.43 Million in 2023, expanding at a CAGR of 8.90% from 2024 to 2032.

The intra-abdominal infections market involves products and treatments for infections occurring inside the abdomen. These infections can affect organs like the stomach, intestines, and liver. They are often caused by bacteria and can lead to serious health issues if not treated promptly. The market includes antibiotics, surgical procedures, and medical devices used to manage these infections. With rising cases of obesity and other health conditions, the demand for effective treatments is growing. Overall, this market plays a crucial role in improving patient outcomes and healthcare quality.

Intra-Abdominal Infections Market- Market Dynamics

Rising antibiotic resistance fuels the demand for advanced treatment options.

Rising antibiotic resistance is increasing the demand for better treatments for intra-abdominal infections. As standard antibiotics become less effective, healthcare providers struggle to manage these infections. The Centres for Disease Control and Prevention (CDC) report that nearly 3 million antibiotic-resistant infections happen in the U.S. each year, highlighting the urgent need for new therapies. This issue not only affects patients' health but also puts a heavy strain on healthcare systems.

In response, researchers and pharmaceutical companies are working on new solutions, including novel antibiotics and alternative therapies. The goal is to develop these advanced treatments to improve patient outcomes and tackle infections that traditional methods can't manage anymore. This shift is crucial for ensuring better healthcare in the face of rising resistance.

Intra-Abdominal Infections Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.90% over the forecast period (2024-2032)

Based on Treatment segmentation, Beta-lactams was predicted to show maximum market share in the year 2023

Based on Application segmentation, Intra-Abdominal Abscesses was the leading type in 2023

Based on Diagnosis segmentation, Computed Tomography (CT) was the leading type in 2023

based on Region, North America was the leading revenue generator in 2023

Intra-Abdominal Infections Market- Segmentation Analysis:

The Global Intra-Abdominal Infections Market is segmented based on Diagnosis, Application, Treatment, and Region.

The market is divided into three categories based on Treatment: Chloramphenicol, Beta Lactams, Quinolones, and Aminoglycosides. In the Intra-Abdominal Infections market, Beta-lactams are the leading treatment option. They are popular because they effectively target a wide range of bacteria, including both gram-positive and gram-negative types commonly associated with these infections.

Beta-lactams, such as penicillin and cephalosporins, are often the first choice for treatment due to their effectiveness and good safety record. They can also penetrate tissues easily, making them effective against intra-abdominal germs. As more surgeries are performed, leading to a rise in infections, the demand for Beta-lactamases continues to grow, reinforcing their top position in this market segment.

The market is divided into five categories based on Application: Intra-abdominal Abscess, Appendicitis, Diverticulitis, diarrhea, Food Poisoning, Infection by Helicobacter Pylori, and Others. In the Intra-Abdominal Infections market, the most dominant segment is Intra-Abdominal Abscesses. These are common in clinical settings and often occur as complications from conditions like appendicitis and diverticulitis. Intra-abdominal abscesses can lead to issues, such as sepsis, which makes quick and effective treatment essential. The need for surgery and antibiotic therapy to treat these infections also boost the market.

Intra-Abdominal Infections Market- Geographical Insights

The largest region in the Intra-Abdominal Infections market is North America. This area has a high number of hospitals and advanced healthcare systems, which support the diagnosis and treatment of these infections. The rise in surgical procedures and the increasing prevalence of obesity are leading to more intra-abdominal infections.

There is also strong research and development in new treatments, driven by major healthcare companies. Patients have access to antibiotics and other therapies. The North American market is expected to grow due to increasing awareness of infection management and several contributing factors.

Intra-Abdominal Infections Market- Competitive Landscape:

The intra-abdominal infections market features several players focused on developing effective treatments for these conditions. Merck & Co. leads with a range of antibiotics and innovative therapies. Pfizer Inc. offers a variety of effective medications, while AstraZeneca is known for its research in this field.

AbbVie Inc. focuses on targeted therapies to combat infections, and Bayer AG provides a mix of treatments and supportive care. GSK (GlaxoSmithKline) is also committed to investing in new drug discoveries. As awareness of intra-abdominal infections grows, these companies compete to improve existing products and introduce new therapies, driving market growth.

Recent Developments:

In January 2024, The NPPA reduced prices of antibiotics from Cipla and Wockhardt following their off-patent status, aiming to enhance accessibility and affordability for patients.

In January 2023, BDR Pharmaceuticals launched a new generic antibiotic, Ceftazidime + Avibactam, designed to combat gram-negative infections. This combination aims to enhance treatment options for challenging bacterial pathogens, addressing growing concerns over antibiotic resistance.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INTRA-ABDOMINAL INFECTIONS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Pfizer Inc.
  • Merck & Co., Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Allergan (AbbVie)
  • GlaxoSmithKline plc
  • Eli Lilly and Company
  • Sanofi S.A.
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • Basilea Pharmaceutica Ltd
  • Shionogi & Co., Ltd.
  • Achaogen, Inc.
  • Melinta Therapeutics, Inc.
  • Tetraphase Pharmaceuticals, Inc.
  • The Medicines Company
  • Dr. Reddy's Laboratories Ltd

GLOBAL INTRA-ABDOMINAL INFECTIONS MARKET, BY DIAGNOSIS- MARKET ANALYSIS, 2019 - 2032

  • Abdominal X-ray
  • Blood Tests
  • Computed Tomography (CT)
  • Ultrasound

GLOBAL INTRA-ABDOMINAL INFECTIONS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Intra-abdominal Abscess
  • Appendicitis
  • Diverticulitis
  • Diarrhea
  • Food Poisoning
  • Infection by Helicobacter Pylori
  • Others

GLOBAL INTRA-ABDOMINAL INFECTIONS MARKET, BY TREATMENT- MARKET ANALYSIS, 2019 - 2032

  • Chloramphenicol
  • Beta Lactams
  • Quinolones
  • Aminoglycosides
  • Others

GLOBAL INTRA-ABDOMINAL INFECTIONS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Intra-Abdominal Infections Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Intra-Abdominal Infections Market Snippet by Diagnosis
    • 2.1.2. Intra-Abdominal Infections Market Snippet by Application
    • 2.1.3. Intra-Abdominal Infections Market Snippet by Treatment
    • 2.1.4. Intra-Abdominal Infections Market Snippet by Country
    • 2.1.5. Intra-Abdominal Infections Market Snippet by Region
  • 2.2. Competitive Insights

3. Intra-Abdominal Infections Key Market Trends

  • 3.1. Intra-Abdominal Infections Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Intra-Abdominal Infections Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Intra-Abdominal Infections Market Opportunities
  • 3.4. Intra-Abdominal Infections Market Future Trends

4. Intra-Abdominal Infections Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Intra-Abdominal Infections Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Intra-Abdominal Infections Market Landscape

  • 6.1. Intra-Abdominal Infections Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Intra-Abdominal Infections Market - By Diagnosis

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Diagnosis, 2023 & 2032 (%)
    • 7.1.2. Abdominal X-ray
    • 7.1.3. Blood Tests
    • 7.1.4. Computed Tomography (CT)
    • 7.1.5. Ultrasound
    • 7.1.6. Others

8. Intra-Abdominal Infections Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Intra-abdominal Abscess
    • 8.1.3. Appendicitis
    • 8.1.4. Diverticulitis
    • 8.1.5. Diarrhoea
    • 8.1.6. Food Poisoning
    • 8.1.7. Infection by Helicobacter Pylori
    • 8.1.8. Others

9. Intra-Abdominal Infections Market - By Treatment

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Treatment, 2023 & 2032 (%)
    • 9.1.2. Chloramphenicol
    • 9.1.3. Beta Lactams
    • 9.1.4. Quinolones
    • 9.1.5. Aminoglycosides
    • 9.1.6. Others

10. Intra-Abdominal Infections Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Intra-Abdominal Infections Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Intra-Abdominal Infections Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Intra-Abdominal Infections Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Intra-Abdominal Infections Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Intra-Abdominal Infections Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Intra-Abdominal Infections Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Pfizer Inc.
    • 11.2.2. Merck & Co., Inc.
    • 11.2.3. AstraZeneca PLC
    • 11.2.4. Bayer AG
    • 11.2.5. Allergan (AbbVie)
    • 11.2.6. GlaxoSmithKline plc
    • 11.2.7. Eli Lilly and Company
    • 11.2.8. Sanofi S.A.
    • 11.2.9. F. Hoffmann-La Roche Ltd
    • 11.2.10. Johnson & Johnson
    • 11.2.11. Basilea Pharmaceutica Ltd
    • 11.2.12. Shionogi & Co., Ltd.
    • 11.2.13. Achaogen, Inc.
    • 11.2.14. Melinta Therapeutics, Inc.
    • 11.2.15. Tetraphase Pharmaceuticals, Inc.
    • 11.2.16. The Medicines Company
    • 11.2.17. Dr. Reddy's Laboratories Ltd

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제